Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats

References

• Edvinsson L, Villalón CM, Maassenvandenbrink A. Basic mechanisms of migraine and its acute treatment. Pharmacol Ther. 2012;136:319–333. doi:10.1016/j.pharmthera.2012.08.01122939884
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007;13:39–44. doi:10.1016/j.molmed.2006.11.00517141570
   PubMed Web of Science ®Google Scholar
• May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12:455–464. doi:10.1038/nrneurol.2016.9327389092
   PubMed Web of Science ®Google Scholar
• Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3–20. doi:10.1111/head.1249925600718
   PubMed Web of Science ®Google Scholar
• Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–660. doi:10.1038/nm0795-6587585147
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Puri V, Puri S. Serotonin and CGRP in migraine. Ann Neurosci. 2012;19:88–94. doi:10.5214/ans.0972.7531.1219021025205974
   PubMedGoogle Scholar
• Kim G-M, Jin K-S, Chung C-S. Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine. Cephalalgia. 2008;28:1179–1187. doi:10.1111/j.1468-2982.2008.01667.x18727644
   PubMed Web of Science ®Google Scholar
• Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev. 1993;5:159–177.8217498
   PubMedGoogle Scholar
• Russo AF. Calcitonin Gene-Related Peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol. 2015;55:533–552. doi:10.1146/annurev-pharmtox-010814-12470125340934
   PubMed Web of Science ®Google Scholar
• Cuesta MC, Quintero L, Pons H, Substance S-RH. P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem Int. 2002;40:301–306. doi:10.1016/S0197-0186(01)00094-811792459
   PubMed Web of Science ®Google Scholar
• Reuter U, Chiarugi A, Bolay H, Moskowitz M. Nuclear factor-kappaB as a molecular target for migraine therapy. Headache J Head Face Pain. 2003;43:426–427. doi:10.1046/j.1526-4610.2003.03085_11.x
   Google Scholar
• Trainor DC, Jones RC. Headaches in explosive magazine workers. Arch Environ Health. 1966;12:231–234. doi:10.1080/00039896.1966.106643624955009
   PubMed Web of Science ®Google Scholar
• Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003;4:386–398. doi:10.1038/nrn110212728266
   PubMed Web of Science ®Google Scholar
• Shelke S, Shahi S, Jalalpure S, Dhamecha D. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies. J Liposome Res. 2016;26:313–323. doi:10.3109/08982104.2015.113223226758957
   PubMed Web of Science ®Google Scholar
• Girotra P, Singh SK, Kumar G. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach. Int J Biol Macromol. 2016;85:92–101. doi:10.1016/j.ijbiomac.2015.12.06926724690
   PubMed Web of Science ®Google Scholar
• Lewis DW, Winner P, Hershey AD, Wasiewski WW. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120:390–396. doi:10.1542/peds.2007-008517671066
   PubMed Web of Science ®Google Scholar
• El Nabarawi M, Abdelmonem R, Attia AM. Formulation and evaluation of intranasal granisetron hydrochloride spanlastic dispersions for postoperative and cancer associated therapies. Inventi Impact Pharm Tech. 2016;2016:126–131.
   Google Scholar
• Abdelmonem R, el Nabarawi M, Attia A. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats. Drug Deliv. 2018;25(1):70–77. doi:10.1080/10717544.2017.141344729228824
   PubMed Web of Science ®Google Scholar
• Jafarieh O, Md S, Ali M, et al. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Dev Ind Pharm. 2015;41:1674–1681. doi:10.3109/03639045.2014.99140025496439
   PubMed Web of Science ®Google Scholar
• Kakkar S, Kaur IP. Spanlastics A novel nanovesicular carrier system for ocular delivery. Int J Pharm. 2011;413:202–210. doi:10.1016/j.ijpharm.2011.04.02721540093
   PubMed Web of Science ®Google Scholar
• Acharjya SK, Rao MEB, Kumar BVVR, Annapurna MMUV. Spectrophotometric methods for the determination of zolmitriptan in bulk and pharmaceutical dosage forms. J Adv Sci Res. 2011;2:42–47.
   Google Scholar
• Kumar B, Roy M, Kumar N, Kumar B, Tyagi PK, Khan K. Non-ionic surfactant vesicles of silymarin: formulation development and evaluation. Int J Pharm Sci Rev Res. 2014;29:1–5.
   Google Scholar
• Fahmy AM, El-Setouhy DA, Ibrahim AB, Habib BA, Tayel SA, Bayoumi NA. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Drug Deliv. 2018;25(1):12–22. doi:10.1080/10717544.2017.141026229219628
   PubMed Web of Science ®Google Scholar
• Zeng W, Li Q, Wan T, et al. Hyaluronic acid-coated spanlastics facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces. 2016;141:28–35. doi:10.1016/j.colsurfb.2016.01.01426820107
   PubMed Web of Science ®Google Scholar
• Sohrabi S, Haeri A, Mahboubi A, Mortazavi A, Dadashzadeh S. Chitosan gel-embedded moxifloxacin spanlastics: an efficient antimicrobial hybrid system for burn infection. Int J Biol Macromol. 2016;85:625–633. doi:10.1016/j.ijbiomac.2016.01.01326794314
   PubMed Web of Science ®Google Scholar
• Jain S, Vyas SP. Mannosylated spanlastics as carrier adjuvant system for topical immunization. J Pharm Pharmacol. 2005;57:1177–1184. doi:10.1211/jpp.57.9.001216105238
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Q, Qi D, et al. Valproate ameliorates nitroglycerin-induced migraine in trigeminal nucleus caudalis in rats through inhibition of NF-кB. J Headache Pain. 2016;17:49. doi:10.1186/s10194-016-0631-z
   PubMed Web of Science ®Google Scholar
• Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, Charles A. Characterization of a novel model of chronic migraine. Pain. 2014;155:269–274. doi:10.1016/j.pain.2013.10.00424121068
   PubMed Web of Science ®Google Scholar
• Cui Z, Chen L, Bei G, et al. Tetrandrine attenuates NF-kB activation in trigeminal ganglia by blocking calcium channel in a rat model of migraine. J Medi Plants Res. 2011;5(25):6032–6039.
   Google Scholar
• Yao G, Man Y, Luo X, et al. Rizatriptan benzoate influences the endogenous pain modulatory system in a rat model of migraine. Neural Regen Res. 2012;7(2):131–135. doi:10.3969/j.issn.1673-5374.2012.02.00925767488
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99:306–314. doi:10.1016/j.cmpb.2010.01.00720176408
   PubMed Web of Science ®Google Scholar
• Worldwide MI. Dynamic light scattering, common terms defined. Inform White Paper. Malvern, UK: Malvern Instruments Limited; 2011:1–6.
   Google Scholar
• Bini KB, Akhilesh D, Prabhakara P, Kamath JV. Development and characterization of non-ionic surfactant vesicles (spanlastics) for oral delivery of lornoxicam. Int J Drug Dev Res. 2012;4:147–154.
   Google Scholar
• Greco R, Meazza C, Mangione AS, et al. Temporal profile of vascular changes induced by systemic nitroglycerine in the meningeal and cortical districts. Cephalgia. 2011;31:190–198. doi:10.1177/0333102410379887
   PubMed Web of Science ®Google Scholar
• Christiansen I, Versen HK, Olesen J, et al. Nitric oxide- induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5 mononitrate. Headache Pain. 2008;9:215–220. doi:10.1007/s10194-008-0043-9
   PubMed Web of Science ®Google Scholar
• Jim B. Could glial activation be a factor in migraine? Med Hypotheses. 2009;72:255–257. doi:10.1016/j.mehy.2008.09.04819036526
   PubMed Web of Science ®Google Scholar
• Monteith T, Goadsby PJ. Acute migraine therapy: new drugs and new approaches current treatment option. Neurol. 2011;13(1):1–14.
   PubMed Web of Science ®Google Scholar
• Arulmozhi DK, Veeranjaneyulu A, Bodlhamkar SL. Migraine:current concepts and emerging therapies. Vasc Pharmacol. 2005;43(3):176–187. doi:10.1016/j.vph.2005.07.001
   PubMed Web of Science ®Google Scholar
• Akbari V, Abedi D, Sadeghi- Aliabadi H. Release studies on ciprofloxacin loaded non-ionic surfactant vesicles. Avicenna J Med Biotechnol. 2015;7(2):69–75.26140184
   PubMedGoogle Scholar
• Khezri FA, Lakshmi CSR, Nargund SL, et al. Analgesic effect of zolmitriptan nanoparticles in experimental animal models. IJIRMS. 2018;3(7):2103–2107.
   Google Scholar
• Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia. 1999;19(7):660–667. doi:10.1046/j.1468-2982.1999.019007660.x10524660
   PubMed Web of Science ®Google Scholar
• Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010;7(2):183–190. doi:10.1016/j.nurt.2010.03.00620430317
   PubMed Web of Science ®Google Scholar
• Bates EA, Nikai T, Brennan KC, et al. Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. Cephalalgia. 2010;30(2):170–178. doi:10.1111/j.1468-2982.2009.01864.x19489890
   PubMed Web of Science ®Google Scholar
• Markovics A, Kormos V, Gaszner B, et al. Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis. 2012;45(1):633–644. doi:10.1016/j.nbd.2011.10.01022033344
   PubMed Web of Science ®Google Scholar
• Bohotin C, Alexa T, Luca A, et al. The effects of intrathecal methylene blue and glyceryl trinitrate administration on orofacial pain in mice. Int J Clin Neurosci Mental Health. 2016;3(suppl.1):s17. doi:10.21035/ijcnmh
   Google Scholar